GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs.
GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from early-stages to late development and pre-commercialization stages, is illustrated through the successful 52-week readout of its Phase 3 trial (ELATIVE®) evaluating elafibranor in Primary Biliary Cholangitis (PBC).
Today, GENFIT has a diversified R&D pipeline covering several therapeutic areas: five programs in acute on chronic liver failure (ACLF) are in clinical stages (Phase 2) and pre-clinical stages, including hepatic encephalopathy (HE), one of the main complications of ACLF; a Phase 2 clinical program targeting cholangiocarcinoma; and a preclinical program targeting urea cycle disorders (UCD) and organic acidemias (OA). GENFIT’s pipeline also includes a diagnostic franchise focused on Metabolic dysfunction-associated steatohepatitis (MASH, formerly known as nonalcoholic steatohepatitis or NASH) and ammonia. GENFIT has facilities in Lille and Paris (France), Zurich (Switzerland) and Cambridge, MA (USA).
GENFIT is a publicly traded company listed on the Nasdaq Global Select Market and on compartment B of Euronext’s regulated market in Paris (Nasdaq and Euronext: GNFT). In 2021, IPSEN became one of GENFIT’s largest shareholders and holds 8% of the company’s share capital.
Company Details
- Employees
- 208
- Founded
- -
- Address
- Parc Eurasanté, 885,avenue Eugène Avinée,united States
- Phone
- 33320164001
- Industry
- Biotechnology
- Website
- genfit.com
- Keywords
- Drug Discovery, Drug Development, Liver disease, Clinical trial, ACLF, Cholestatic Diseases, HepaticEncephalopathy, Cholangiocarcinoma, Therapeutics, Diagnostics, UreaCycleDisorder.
- HQ
- Loos, Hauts-de-France
Genfit Questions
Genfit's helpline number is 33320164001
Genfit's website is genfit.com
Genfit's LinkedIn profile is https://www.linkedin.com/company/genfit
Genfit has
208 employees.
View email and phone details for 208
employees at Genfit.
Genfit's industry is
Biotechnology
Genfit's top competitors are
Bioaster,
Cellectis,
Nanobiotix,
Maat Pharma,
Abivax,
Valneva,
Innate Pharma,
Phaxiam Therapeutics,
Transgene,
Ose Immunotherapeutics.
Genfit's categories are Biotechnology
Genfit's founding year is 1999
